Janssen Korea Ltd. and Johnson & Johnson Innovation LLC have announced the launch of the Seoul Innovation QuickFire ...
South Korea based PharmAbcine, a biotech company focusing on the development of antibody therapeutics, announced that it...
Nine Technology, a Korean correct posture device manufacturing company, has recently been promoting hihip, pelvic care p...
Japanese firm Eisai Co., Ltd. has announced that Eisai Korea Inc., Eisai’s subsidiary in South Korea, has received...
South Korea based medical artificial intelligence (AI) solution development company VUNO Inc. and a member com...
A Korean molecular diagnostic company, Gencurix, Inc., has announced that they have received U.S. Food and Drug Administ...
The leading Asia-Pacific biotech specialist CRO Novotech has partnered with South Korea’s world-class 1,...
South Korea based Genexine has announced that it is the first domestic pharmaceutical company to have been approved for ...
HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...
The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific Rehabilitation ...
US based Bright Pattern, a leading provider of AI-powered cloud contact center software for innovative co...
South Korea's Yuyu Pharma and SD BIOSENSOR entered into a Supply Agreement, where Yuyu Pharma will export COVID-19 ...
Celltrion Group has announced plans to expand its diagnostic portfolio for SARS-CoV-2, the virus causing COVID-19, in it...
South Korean company Lunit has announced that its AI solution for breast cancer, Lunit INSIGHT MMG, has been CE certifie...
Korean firm PharmAbcine Inc. has entered into a strategic partnership with Thermo Fisher Scientific for the de...
SK Biopharmaceuticals announced on 29 May 2020 that Jeong Woo Cho, President and CEO of SK Biopharmaceuticals, has rec...
Korean firm PharmAbcine, a clinical-stage biotechnology company, announced that the company entered into a license agree...
US based INOVIO, the International Vaccine Institute (IVI), and Seoul National University Hospital have announ...
